Free Trial
NYSE:TDOC

Teladoc Health (TDOC) Stock Price, News & Analysis

Teladoc Health logo
$7.16 -0.17 (-2.32%)
As of 03:59 PM Eastern

About Teladoc Health Stock (NYSE:TDOC)

Key Stats

Today's Range
$7.07
$7.30
50-Day Range
$6.52
$11.40
52-Week Range
$6.35
$15.21
Volume
7.47 million shs
Average Volume
6.22 million shs
Market Capitalization
$1.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.46
Consensus Rating
Hold

Company Overview

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

Teladoc Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
72nd Percentile Overall Score

TDOC MarketRank™: 

Teladoc Health scored higher than 72% of companies evaluated by MarketBeat, and ranked 371st out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Teladoc Health has received a consensus rating of Hold. The company's average rating score is 2.39, and is based on 7 buy ratings, 11 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Teladoc Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Teladoc Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Teladoc Health are expected to grow in the coming year, from ($1.16) to ($0.98) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Teladoc Health is -1.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Teladoc Health is -1.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Teladoc Health has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Teladoc Health's valuation and earnings.
  • Percentage of Shares Shorted

    11.86% of the float of Teladoc Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Teladoc Health has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Teladoc Health has recently decreased by 6.86%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Teladoc Health does not currently pay a dividend.

  • Dividend Growth

    Teladoc Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.86% of the float of Teladoc Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Teladoc Health has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Teladoc Health has recently decreased by 6.86%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Teladoc Health has a news sentiment score of -0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Teladoc Health this week, compared to 9 articles on an average week.
  • Search Interest

    38 people have searched for TDOC on MarketBeat in the last 30 days. This is an increase of 31% compared to the previous 30 days.
  • MarketBeat Follows

    Only 5 people have added Teladoc Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Teladoc Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $92,713.00 in company stock.

  • Percentage Held by Insiders

    Only 0.58% of the stock of Teladoc Health is held by insiders.

  • Percentage Held by Institutions

    76.82% of the stock of Teladoc Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Teladoc Health's insider trading history.
Receive TDOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter.

TDOC Stock News Headlines

Teladoc Health, Inc. (TDOC) Q1 2025 Earnings Call Transcript
Teladoc shares fall as Q1 earnings miss expectations
Top performing AI play of the decade…? (The answer will shock you)
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is about to announce could change the AI market once again. Experts already predict the total addressable market could climb past $20 trillion. But Sykes believes most investors have missed what’s coming next. He’s tracking a new shift — and says the biggest gains are still ahead.
Teladoc: Q1 Earnings Snapshot
Teladoc’s (NYSE:TDOC) Q1 Sales Beat Estimates
Teladoc Health Reports First Quarter 2025 Results
See More Headlines

TDOC Stock Analysis - Frequently Asked Questions

Teladoc Health's stock was trading at $9.09 at the beginning of the year. Since then, TDOC shares have decreased by 21.2% and is now trading at $7.16.
View the best growth stocks for 2025 here
.

Teladoc Health, Inc. (NYSE:TDOC) posted its quarterly earnings data on Wednesday, February, 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by $0.07. The health services provider earned $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. Teladoc Health had a negative trailing twelve-month return on equity of 10.06% and a negative net margin of 37.91%.
Read the conference call transcript
.

The following companies are subsidiaries of Teladoc Health: Livongo, Intouch Health, MedecinDirect, TelaDietitian, Advance Medical, Best Doctors, CogCubed, and more.

Teladoc Health (TDOC) raised $112 million in an IPO on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Teladoc Health's top institutional investors include Robeco Institutional Asset Management B.V. (0.40%), IMC Chicago LLC, Bank of New York Mellon Corp (0.31%) and Allspring Global Investments Holdings LLC (0.16%). Insiders that own company stock include Jason N Gorevic, Laizer Kornwasser, Mala Murthy, Michael Willem Waters, Nikolaos P Nanis, Adam C Vandervoort, Stephany Verstraete, Arnnon Geshuri, Andrew Turitz, Thomas Mckinley, Karen L Daniel, Vidya Raman-Tangella, Daniel Trencher, Richard J Napolitano, James L Cave, Claus Torp Jensen and Carlos Nueno.
View institutional ownership trends
.

Shares of TDOC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Teladoc Health investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Salesforce (CRM), Advanced Micro Devices (AMD) and PayPal (PYPL).

Company Calendar

Last Earnings
2/26/2025
Today
4/30/2025
Next Earnings (Estimated)
4/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
Healthcare
Current Symbol
NYSE:TDOC
Fax
N/A
Employees
5,100
Year Founded
2002

Price Target and Rating

Average Stock Price Target
$10.46
High Stock Price Target
$17.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+46.0%
Consensus Rating
Hold
Rating Score (0-4)
2.39
Research Coverage
18 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-220,370,000.00
Pretax Margin
-37.49%

Debt

Sales & Book Value

Annual Sales
$2.57 billion
Cash Flow
$0.46 per share
Price / Cash Flow
15.64
Book Value
$14.05 per share
Price / Book
0.51

Miscellaneous

Free Float
170,531,000
Market Cap
$1.25 billion
Optionable
Optionable
Beta
1.73

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NYSE:TDOC) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners